Works by Mrowietz

Results: 404
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    News and Notices.

    Published in:
    Clinical & Experimental Dermatology, 1995, v. 20, n. 3, p. 282, doi. 10.1111/j.1365-2230.1995.tb01326.x
    By:
    • Mrowietz, U.
    Publication type:
    Article
    13
    14

    Haemocompatibility of Coronary Catheters.

    Published in:
    Biomedical Engineering / Biomedizinische Technik, 2000, v. 45, n. 6, p. 163, doi. 10.1515/bmte.2000.45.6.163
    By:
    • Mrowietz, C.;
    • Bach, R.;
    • Seyfert, U.;
    • Park, J. W.;
    • Franke, R. P.;
    • Jung, F.
    Publication type:
    Article
    15
    16
    17

    Implementing well‐being in the management of psoriasis: An expert recommendation.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 2, p. 302, doi. 10.1111/jdv.19567
    By:
    • Sommer, Rachel;
    • Mrowietz, Ulrich;
    • Gaarn Du Jardin, Kristian;
    • Kasujee, Ismail;
    • Martini, Elisa;
    • Daudén, Esteban;
    • Fabbrocini, Gabriella;
    • Zink, Alexander;
    • Griffiths, Christopher E. M.;
    • Augustin, Matthias
    Publication type:
    Article
    18
    19

    SARS‐CoV‐2 vaccination status and adverse events among patients with psoriasis—Data from the German Registries PsoBest and CoronaBest.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 7, p. e831, doi. 10.1111/jdv.19039
    By:
    • Valencia López, María José;
    • Meineke, Anna;
    • Stephan, Brigitte;
    • Rustenbach, Stephan Jeff;
    • Kis, Anne;
    • Thaçi, Diamant;
    • Mrowietz, Ulrich;
    • Reich, Kristian;
    • Staubach‐Renz, Petra;
    • von Kiedrowski, Ralph;
    • Bogena, Henriette;
    • Augustin, Matthias
    Publication type:
    Article
    20

    Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. 348, doi. 10.1111/jdv.18689
    By:
    • Mrowietz, Ulrich;
    • Barker, Jonathan;
    • Conrad, Curdin;
    • Jullien, Denis;
    • Gisondi, Paolo;
    • Flower, Andrea;
    • Reddy, Jyotsna;
    • Paris, Maria;
    • Picard, Hernan;
    • Jardon, Shauna;
    • Augustin, Matthias
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    A phase 4, randomized, head‐to‐head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate‐to‐severe plaque psoriasis (CHANGE).

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 3, p. 701, doi. 10.1111/jdv.16932
    By:
    • Pinter, A.;
    • Hoffmann, M.;
    • Reich, K.;
    • Augustin, M.;
    • Kaplan, K.;
    • Gudjónsdóttir, S.D.;
    • Delvin, T.;
    • Mrowietz, U.;
    • Beissert, S.;
    • Effendy, I.;
    • Eyerich, K.;
    • Gonser, L.;
    • Kleinheinz, A.;
    • Leitz, N.;
    • Niesmann, J.;
    • Pauser, S.;
    • Philipp, S.;
    • Radny, P.;
    • Rothhaar, A.;
    • Rotterdam, S.
    Publication type:
    Article
    29

    EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 2, p. 281, doi. 10.1111/jdv.16926
    By:
    • Nast, A.;
    • Smith, C.;
    • Spuls, P.I.;
    • Avila Valle, G.;
    • Bata‐Csörgö, Z.;
    • Boonen, H.;
    • De Jong, E.;
    • Garcia‐Doval, I.;
    • Gisondi, P.;
    • Kaur‐Knudsen, D.;
    • Mahil, S.;
    • Mälkönen, T.;
    • Maul, J.T.;
    • Mburu, S.;
    • Mrowietz, U.;
    • Reich, K.;
    • Remenyik, E.;
    • Rønholt, K.M.;
    • Sator, P.G.;
    • Schmitt‐Egenolf, M.
    Publication type:
    Article
    30

    Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 2, p. 431, doi. 10.1111/jdv.16632
    By:
    • Augustin, M.;
    • Dauden, E.;
    • Mrowietz, U.;
    • Konstantinou, M.P.;
    • Gerdes, S.;
    • Kingo, K.;
    • Szepietowski, J.C.;
    • Perrot, J.L.;
    • Cuccia, A.;
    • Rissler, M.;
    • Gathmann, S.;
    • Sieder, C.;
    • Orsenigo, R.;
    • Jagiello, P.;
    • Bachhuber, T.
    Publication type:
    Article
    31
    32
    33

    EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 11, p. 2461, doi. 10.1111/jdv.16915
    By:
    • Nast, A.;
    • Smith, C.;
    • Spuls, P.I.;
    • Avila Valle, G.;
    • Bata‐Csörgö, Z.;
    • Boonen, H.;
    • De Jong, E.;
    • Garcia‐Doval, I.;
    • Gisondi, P.;
    • Kaur‐Knudsen, D.;
    • Mahil, S.;
    • Mälkönen, T.;
    • Maul, J.T.;
    • Mburu, S.;
    • Mrowietz, U.;
    • Reich, K.;
    • Remenyik, E.;
    • Rønholt, K.M.;
    • Sator, P.G.;
    • Schmitt‐Egenolf, M.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50